Shelley Crary
Pediatric Hematology-Oncology · Little Rock, ARNPI 1154356533
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $47,950 of the $64,473 with a category attached, or 74.4%. 9 manufacturers reported payments, led by CSL Behring at 34.4% of the total.
Across 78 payments — averaging $826.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$22K
- Genentech USA, Inc.$12K
- Sanofi$10K
- Pfizer$6K
- Novartis$6K
- Global Blood Therapeutics, Inc.$3K
- plus $5K from 3 others
Across 158 payments — averaging $3024.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$128K
- Takeda Pharmaceuticals U.S.A., Inc.$114K
- CSL Behring$76K
- American Regent$51K
- Janssen Research & Development, LLC$28K
- AMAG Pharmaceuticals, Inc.$19K
- plus $63K from 5 others
What the payments were for
- Consulting fees$47,95074%
- Speaking & faculty fees$8,18613%
- Travel & lodging$6,33910%
- Food & beverage$1,9983%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 23 | $22,192 |
| Genentech USA, Inc. | 14 | $12,453 |
| Sanofi | 9 | $10,400 |
| Pfizer | 21 | $5,757 |
| Novartis | 6 | $5,739 |
| Global Blood Therapeutics, Inc. | 2 | $2,620 |
| Medexus Pharma, Inc. | 1 | $2,600 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,688 |
| Bayer | 1 | $1,024 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 13 | $349 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Little Rock
- Kevin BielamowiczLittle Rock$100K
- Kimo StineLittle Rock$31K
- Michael BishopLittle Rock$10K
- Divyaswathi Citla SridharLittle Rock$3K
- Smitha Hosahalli VasannaLittle Rock$394
- Lauren AppellLittle Rock$292
- Jason FarrarLittle Rock$171
- Carolyn SaccenteLittle Rock$124
- Joana MackLittle Rock$90
- Medhavi HonharLittle Rock$42
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.